{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+for+Statins&page=2", "query": { "intervention": "Placebo for Statins", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+for+Statins&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-28T11:05:30.930Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02634151", "title": "A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypercholesteremia" ], "interventions": [ { "name": "Gemcabene", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "NeuroBo Pharmaceuticals Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 105, "start_date": "2016-11", "completion_date": "2017-08", "has_results": true, "last_update_posted_date": "2020-06-25", "last_synced_at": "2026-09-28T11:05:30.930Z", "location_count": 24, "location_summary": "Birmingham, Alabama • Beverly Hills, California • Huntington Park, California + 19 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Huntington Park", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Atlantis", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02634151" }, { "nct_id": "NCT01717586", "title": "Pravastatin for Prevention of Preeclampsia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Preeclampsia" ], "interventions": [ { "name": "Pravastatin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "The University of Texas Medical Branch, Galveston", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 48, "start_date": "2012-08", "completion_date": "2024-02-12", "has_results": false, "last_update_posted_date": "2025-05-04", "last_synced_at": "2026-09-28T11:05:30.930Z", "location_count": 3, "location_summary": "Chicago, Illinois • Pittsburgh, Pennsylvania • Galveston, Texas", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Galveston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01717586" }, { "nct_id": "NCT01663402", "title": "ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atherosclerotic Cardiovascular Disease" ], "interventions": [ { "name": "Alirocumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "LMT", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 18924, "start_date": "2012-10", "completion_date": "2018-01-23", "has_results": true, "last_update_posted_date": "2019-03-18", "last_synced_at": "2026-09-28T11:05:30.930Z", "location_count": 273, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 218 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01663402" }, { "nct_id": "NCT02714569", "title": "A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Dyslipidemias" ], "interventions": [ { "name": "LY3202328", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Simvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 60, "start_date": "2016-03", "completion_date": "2017-02-15", "has_results": true, "last_update_posted_date": "2021-05-25", "last_synced_at": "2026-09-28T11:05:30.930Z", "location_count": 4, "location_summary": "Miami, Florida • Lenexa, Kansas • Marlton, New Jersey + 1 more", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Lenexa", "state": "Kansas" }, { "city": "Marlton", "state": "New Jersey" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT02714569" }, { "nct_id": "NCT06538649", "title": "Effect of Statins on Crohn's Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Crohn's Ileocolitis", "Crohn Disease" ], "interventions": [ { "name": "Rosuvastatin", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 20, "start_date": "2024-12-12", "completion_date": "2028-10-31", "has_results": false, "last_update_posted_date": "2026-02-27", "last_synced_at": "2026-09-28T11:05:30.930Z", "location_count": 1, "location_summary": "Stanford, California", "locations": [ { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06538649" }, { "nct_id": "NCT00687076", "title": "Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Peripheral Arterial Disease" ], "interventions": [ { "name": "Ezetimibe", "type": "DRUG" }, { "name": "Niaspan", "type": "DRUG" }, { "name": "Statin therapy", "type": "DRUG" }, { "name": "Standard care", "type": "BEHAVIORAL" }, { "name": "Aspirin", "type": "DRUG" }, { "name": "Clopidogrel", "type": "DRUG" }, { "name": "Placebo Niaspan", "type": "DRUG" }, { "name": "Placebo Ezetimibe", "type": "DRUG" }, { "name": "Percutaneous transluminal angioplasty (PTA)", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "BEHAVIORAL", "PROCEDURE" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 102, "start_date": "2004-04", "completion_date": "2010-12", "has_results": true, "last_update_posted_date": "2020-02-06", "last_synced_at": "2026-09-28T11:05:30.930Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00687076" }, { "nct_id": "NCT00532311", "title": "Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With Hypercholesterolemia", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypercholesterolemia" ], "interventions": [ { "name": "Lapaquistat acetate and stable statin therapy", "type": "DRUG" }, { "name": "Stable statin therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 411, "start_date": "2007-07", "completion_date": "2008-04", "has_results": false, "last_update_posted_date": "2016-06-22", "last_synced_at": "2026-09-28T11:05:30.930Z", "location_count": 86, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 83 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00532311" }, { "nct_id": "NCT00367458", "title": "Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV" ], "interventions": [ { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2006-10-18", "completion_date": "2008-06-19", "has_results": true, "last_update_posted_date": "2020-02-26", "last_synced_at": "2026-09-28T11:05:30.930Z", "location_count": 3, "location_summary": "San Diego, California • Bethesda, Maryland", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Bethesda", "state": "Maryland" }, { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00367458" }, { "nct_id": "NCT00065806", "title": "Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Lupus Erythematosus, Systemic" ], "interventions": [ { "name": "Atorvastatin", "type": "DRUG" }, { "name": "Placebo atorvastatin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Laura Schanberg", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "10 Years to 21 Years" }, "enrollment_count": 221, "start_date": "2003-09", "completion_date": "2009-12", "has_results": true, "last_update_posted_date": "2013-08-15", "last_synced_at": "2026-09-28T11:05:30.930Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00065806" }, { "nct_id": "NCT01408303", "title": "[E]PANOVA Combined With a [S]TATIN in [P]ATIENTS With HYPERT[R]IGLYCER[I]DEMIA to Reduce Non-HDL CHOLES[T]EROL", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertriglyceridemia", "Cardiovascular Disease" ], "interventions": [ { "name": "Olive oil, 4g", "type": "DRUG" }, { "name": "omega-3-carboxylic acids, 2g", "type": "DRUG" }, { "name": "omega-3-carboxylic acids, 4g", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 646, "start_date": "2011-08", "completion_date": "2012-06", "has_results": true, "last_update_posted_date": "2014-12-05", "last_synced_at": "2026-09-28T11:05:30.930Z", "location_count": 89, "location_summary": "Muscle Shoals, Alabama • Chandler, Arizona • Phoenix, Arizona + 78 more", "locations": [ { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Encinitas", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01408303" } ] }